One biotech is look­ing to lessen an­tipsy­chot­ic-in­duced weight gain, de­spite new en­trants

Re­sponse Phar­ma­ceu­ti­cals be­lieves its ex­per­i­men­tal drug can lessen the per­sis­tent weight gain as­so­ci­at­ed with an­tipsy­chotics.

In a new pi­lot study, the com­pa­ny as­sessed RDX-002 in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER